title: [Hypertension in acromegaly].
authors.affiliation: Department of Internal Medicine, Keio University School of Medicine.
authors.forename: Hiroo
authors.initials: H
authors.lastname: Kumagai
authors.forename: Toshiko
authors.initials: T
authors.lastname: Onami
authors.forename: Kamon
authors.initials: K
authors.lastname: Iigaya
authors.forename: Koichi
authors.initials: K
authors.lastname: Hayashi
authors.forename: Takao
authors.initials: T
authors.lastname: Saruta
mesh_terms: D000172:Acromegaly / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D001794:Blood Pressure; D001971:Bromocriptine / Q000627:therapeutic use; D002940:Circadian Rhythm; D019382:Human Growth Hormone / Q000502:physiology; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology*; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D015282:Octreotide / Q000627:therapeutic use; D010953:Plasma Volume; D012964:Sodium / Q000378:metabolism; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014655:Vascular Resistance
chemical_list: D019382:Human Growth Hormone; D001971:Bromocriptine; D007334:Insulin-Like Growth Factor I; D012964:Sodium; D015282:Octreotide